CBD Pill Study for Healthy Men
Treatments studied
This study tests how two different CBD pills are absorbed by the body. It is for healthy men aged 18-35 and involves two one-day clinic visits with blood draws.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a male between 18 and 35 years old
- Be generally healthy (no serious medical conditions)
- No use of cannabis or CBD in the last 2 months
- Not take certain medications like antidepressants or narcotics for at least a week
- Able to stay at the clinic for 13 hours on two separate days
- Able to come back for follow-up blood draws
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether a CBD pill (compared with a placebo sugar pill) can affect cannabis use and stress in people ages 18–25 who use cannabis very frequently. It may help your stress levels and cannabis-related symptoms while researchers carefully monitor safety and abstinence periods during visits.
This Phase 1/2 study tests whether inhaled cannabidiol (CBD) is safe and well-tolerated in healthy people who use cannabis occasionally. You’d be asked to avoid other cannabis and certain drugs around study visits so researchers can measure your response clearly.
This study tests whether cannabidiol (CBD) can help young adults who use cannabis heavily but aren't looking to quit. You'll take a CBD pill and see if it changes your cannabis use or related symptoms.
This study tests the safety and how the body processes a cannabis extract in healthy volunteers. It helps researchers understand if the extract is safe and how it works before moving to larger studies.
This trial tests a new supplement (VL-SE-01) to see if it is safe and how well it works for people with a stressed lifestyle. If you are a generally healthy adult between 18 and 55 and feel stressed, you may be able to join.
This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.
Hear when a new Pharmacokinetics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.